Martijn R Meijerink

Summary

Affiliation: VU University Medical Center
Country: The Netherlands

Publications

  1. ncbi The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    Eur Radiol 17:1700-13. 2007
  2. ncbi Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    Ultrasound Med Biol 36:1626-36. 2010
  3. ncbi Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases
    Martijn R Meijerink
    Department of Radiology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands
    Eur Radiol 18:2345-54. 2008
  4. ncbi Subtraction-multiphase-CT unbeneficial for early detection of colorectal liver metastases
    Martijn R Meijerink
    Department of Radiology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
    Eur J Radiol 74:e132-7. 2010
  5. ncbi Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    Acad Radiol 16:1215-22. 2009
  6. ncbi Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience
    Martijn R Meijerink
    Department of Radiology, VU University Medical Centre, Amsterdam, The Netherlands
    Eur J Radiol 77:167-71. 2011
  7. ncbi Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
    Joline S W Lind
    Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
    Eur Radiol 20:2890-8. 2010
  8. ncbi MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system
    Stijn J B van Weyenberg
    Department of Gastroenterology, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Radiology 259:151-61. 2011
  9. ncbi Positive predictive value of computed tomography coronary angiography in clinical practice
    Jan G J Groothuis
    Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands
    Int J Cardiol 156:315-9. 2012
  10. ncbi Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours
    Hester van Cruijsen
    Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Cancer 46:901-11. 2010

Detail Information

Publications14

  1. ncbi The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    Eur Radiol 17:1700-13. 2007
    ..In conclusion, CTP is feasible in showing changes of perfusion induced by anti-angiogenic therapy...
  2. ncbi Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
    Ultrasound Med Biol 36:1626-36. 2010
    ..However, both techniques cannot be used interchangeably. DCE-US should be restricted for studies in which a considerable change in perfusion is expected and for patients with a relatively high tumor blood flow at baseline...
  3. ncbi Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases
    Martijn R Meijerink
    Department of Radiology, Vrije Universiteit Medical Center, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands
    Eur Radiol 18:2345-54. 2008
    ..046) and specificity to 82.6 from 78.3% (P=0.074). Total -liver-volume CTP is a noninvasive, quantitative, and feasible technique. Preliminary results suggest an improved detection of liver metastases for CTP compared to four-phase CT...
  4. ncbi Subtraction-multiphase-CT unbeneficial for early detection of colorectal liver metastases
    Martijn R Meijerink
    Department of Radiology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands
    Eur J Radiol 74:e132-7. 2010
    ..To assess the value of multiphase-subtraction-CT for early detection of colorectal-liver-metastases (CRLM)...
  5. ncbi Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience
    Martijn R Meijerink
    Department of Radiology, VU University Medical Center, De Boelelaan 1117, Postbus 7057 Amsterdam, The Netherlands
    Acad Radiol 16:1215-22. 2009
    ..The aim of this study was to prospectively evaluate the feasibility of a novel total liver volume perfusion computed tomographic technique in demonstrating treatment-site recurrence of liver metastases after radiofrequency ablation (RFA)...
  6. ncbi Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience
    Martijn R Meijerink
    Department of Radiology, VU University Medical Centre, Amsterdam, The Netherlands
    Eur J Radiol 77:167-71. 2011
    ..5 cm) remain high. The objective of this study was to evaluate the safety, feasibility and local effectiveness of a novel bipolar plan-parallel expandable system for these larger tumours...
  7. ncbi Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
    Joline S W Lind
    Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands
    Eur Radiol 20:2890-8. 2010
    ....
  8. ncbi MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system
    Stijn J B van Weyenberg
    Department of Gastroenterology, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Radiology 259:151-61. 2011
    ....
  9. ncbi Positive predictive value of computed tomography coronary angiography in clinical practice
    Jan G J Groothuis
    Interuniversity Cardiology Institute of The Netherlands, Utrecht, The Netherlands
    Int J Cardiol 156:315-9. 2012
    ..Thus, the PPV of CTCA in patients that undergo CTCA as part of a clinical diagnostic evaluation remains unclear. This study investigated the PPV of CTCA for the detection of significant CAD in clinical practice...
  10. ncbi Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumours
    Hester van Cruijsen
    Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Eur J Cancer 46:901-11. 2010
    ..Combination treatment with cediranib and gefitinib, an EGFR signalling inhibitor, was evaluated in patients with advanced solid tumours...
  11. ncbi Targeted therapies in renal cell cancer: recent developments in imaging
    Astrid A M van der Veldt
    Department of Nuclear Medicine and PET Research, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands
    Target Oncol 5:95-112. 2010
    ....
  12. ncbi Low to intermediate probability of coronary artery disease: comparison of coronary CT angiography with first-pass MR myocardial perfusion imaging
    Jan G J Groothuis
    Department of Cardiology, VU University Medical Center, De Boelelaan 1117, Room 5F003, 1081 HV Amsterdam, The Netherlands
    Radiology 254:384-92. 2010
    ..To compare coronary computed tomographic (CT) angiography with first-pass magnetic resonance (MR) myocardial perfusion imaging in patients with chest pain and low to intermediate probability of coronary artery disease (CAD)...
  13. ncbi MR enteroclysis in the diagnosis of small-bowel neoplasms
    Stijn J B van Weyenberg
    Departments of Gastroenterology and Hepatology, Radiology, and Surgery, VU University Medical Center, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands
    Radiology 254:765-73. 2010
    ..95 for MR enteroclysis in the detection of small-bowel neoplasms. (c) RSNA, 2010 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.09090828/-/DC1...
  14. ncbi Sunitinib for treatment of advanced renal cell cancer: primary tumor response
    Astrid A M van der Veldt
    Department of Medical Oncology, VU University Medical Center, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Clin Cancer Res 14:2431-6. 2008
    ..In addition, the primary tumor is known to be refractory to cytokines. Sunitinib is now approved for treatment of advanced RCC, but its effect on the primary tumor has yet to be reported...